Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection

被引:0
作者
Belongia, Edward A. [1 ,5 ]
Petrie, Joshua G. [1 ]
Feldstein, Leora R. [3 ]
Guan, Lizheng [2 ]
Halfmann, Peter J. [2 ]
King, Jennifer P.
Neumann, Gabriele [2 ]
Pattinson, David [2 ]
Rolfes, Melissa A. [4 ]
Mclean, Huong Q. [1 ]
Kawaoka, Yoshihiro [2 ]
机构
[1] Marshfield Clin Res Inst, Ctr Clin Epidemiol & Populat Hlth, Marshfield, WI USA
[2] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI USA
[3] CDCP, Coronavirus & Other Resp Viruses Div, Atlanta, GA USA
[4] CDCP, Influenza Div, Atlanta, GA USA
[5] Marshfield Clin Res Inst, Ctr Clin Epidemiol & Populat Hlth, 1000 N Oak Ave ML2, Marshfield, WI 54449 USA
关键词
cross-neutralization; neutralizing antibodies; Omicron; SARS-CoV-2; infection;
D O I
10.1093/jpids/piad109
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We assessed serum neutralization of Omicron BA.5 in children following SARS-CoV-2 infection during the Delta or Omicron BA.1/BA.2 variant period. Convalescent BA.5 titers were higher following infections during the Omicron BA.1/BA.2 vs Delta variant period, and in vaccinated vs unvaccinated children. Titers against BA.5 did not differ by age group. We assessed serum neutralization against antigenically advanced Omicron BA.5 in children following SARS-CoV-2 infection with Delta and Omicron BA.1/2 variants. Post-infection titers to BA.5 were significantly higher for infections during the Omicron period and in vaccinated vs unvaccinated children.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 14 条
[1]   Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study [J].
Adams, Katherine ;
Rhoads, Jillian P. ;
Surie, Diya ;
Gaglani, Manjusha ;
Ginde, Adit A. ;
McNeal, Tresa ;
Talbot, H. Keipp ;
Casey, Jonathan D. ;
Zepeski, Anne ;
Shapiro, Nathan, I ;
Gibbs, Kevin W. ;
Files, D. Clark ;
Hager, David N. ;
Frosch, Anne E. ;
Exline, Matthew C. ;
Mohamed, Amira ;
Johnson, Nicholas J. ;
Steingrub, Jay S. ;
Peltan, Ithan D. ;
Brown, Samuel M. ;
Martin, Emily T. ;
Lauring, Adam S. ;
Khan, Akram ;
Busse, Laurence W. ;
Duggal, Abhijit ;
Wilson, Jennifer G. ;
Chang, Steven Y. ;
Mallow, Christopher ;
Kwon, Jennie H. ;
Chappell, James D. ;
Halasa, Natasha ;
Grijalva, Carlos G. ;
Lindsell, Christopher J. ;
Lester, Sandra N. ;
Thornburg, Natalie J. ;
Park, SoHee ;
McMorrow, Meredith L. ;
Patel, Manish M. ;
Tenforde, Mark W. ;
Self, Wesley H. .
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[2]   SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses [J].
Dejnirattisai, Wanwisa ;
Huo, Jiandong ;
Zhou, Daming ;
Zahradnik, Jiri ;
Supasa, Piyada ;
Liu, Chang ;
Duyvesteyn, Helen M. E. ;
Ginn, Helen M. ;
Mentzer, Alexander J. ;
Tuekprakhon, Aekkachai ;
Nutalai, Rungtiwa ;
Wang, Beibei ;
Dijokaite, Aiste ;
Khan, Suman ;
Avinoam, Ori ;
Bahar, Mohammad ;
Skelly, Donal ;
Adele, Sandra ;
Johnson, Sile Ann ;
Amini, Ali ;
Ritter, Thomas G. ;
Mason, Chris ;
Dold, Christina ;
Pan, Daniel ;
Assadi, Sara ;
Bellass, Adam ;
Omo-Dare, Nicola ;
Koeckerling, David ;
Flaxman, Amy ;
Jenkin, Daniel ;
Aley, Parvinder K. ;
Voysey, Merryn ;
Clemens, Sue Ann Costa ;
Naveca, Felipe Gomes ;
Nascimento, Valdinete ;
Nascimento, Fernanda ;
da Costa, Cristiano Fernandes ;
Resende, Paola Cristina ;
Pauvolid-Correa, Alex ;
Siqueira, Marilda M. ;
Baillie, Vicky ;
Serafin, Natali ;
Kwatra, Gaurav ;
Da Silva, Kelly ;
Madhi, Shabir A. ;
Nunes, Marta C. ;
Malik, Tariq ;
Openshaw, Peter J. M. ;
Baillie, J. Kenneth ;
Semple, Malcolm G. .
CELL, 2022, 185 (03) :467-+
[3]  
Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1016/j.cell.2021.12.033, 10.1101/2021.12.14.21267755]
[4]   Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 [J].
Hachmann, Nicole P. ;
Miller, Jessica ;
Collier, Ai-ris Y. ;
Ventura, John D. ;
Yu, Jingyou ;
Rowe, Marjorie ;
Bondzie, Esther A. ;
Powers, Olivia ;
Surve, Nehalee ;
Hall, Kevin ;
Barouch, Dan H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01) :86-88
[5]  
Lambrou Anastasia S, 2022, MMWR Morb Mortal Wkly Rep, V71, P206, DOI 10.15585/mmwr.mm7106a4
[6]  
Ma KC, 2023, MMWR-MORBID MORTAL W, V72, P651, DOI 10.15585/mmwr.mm7224a2
[7]   mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021 [J].
McLean, Huong Q. ;
McClure, David L. ;
King, Jennifer P. ;
Meece, Jennifer K. ;
Pattinson, David ;
Neumann, Gabriele ;
Kawaoka, Yoshihiro ;
Rolfes, Melissa A. ;
Belongia, Edward A. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (04) :607-612
[8]   Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022 [J].
Petrie, Joshua G. ;
King, Jennifer P. ;
McClure, David L. ;
Rolfes, Melissa A. ;
Meece, Jennifer K. ;
Pattinson, David ;
Neumann, Gabriele ;
Kawaoka, Yoshihiro ;
Belongia, Edward A. ;
McLean, Huong Q. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (03)
[9]   BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants [J].
Roessler, Annika ;
Netzl, Antonia ;
Knabl, Ludwig ;
Schaefer, Helena ;
Wilks, Samuel H. ;
Bante, David ;
Falkensammer, Barbara ;
Borena, Wegene ;
von Laer, Dorothee ;
Smith, Derek J. ;
Kimpel, Janine .
NATURE COMMUNICATIONS, 2022, 13 (01)
[10]   Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants [J].
Servellita, Venice ;
Syed, Abdullah M. ;
Morris, Mary Kate ;
Brazer, Noah ;
Saldhi, Prachi ;
Garcia-Knight, Miguel ;
Sreekumar, Bharath ;
Khalid, Mir M. ;
Ciling, Alison ;
Chen, Pei-Yi ;
Kumar, G. Renuka ;
Gliwa, Amelia S. ;
Nguyen, Jenny ;
Sotomayor-Gonzalez, Alicia ;
Zhang, Yueyuan ;
Frias, Edwin ;
Prostko, John ;
Hackett, John, Jr. ;
Andino, Raul ;
Wadford, Debra A. ;
Hanson, Carl ;
Doudna, Jennifer ;
Ott, Melanie ;
Chiu, Charles Y. .
CELL, 2022, 185 (09) :1539-+